371
Views
19
CrossRef citations to date
0
Altmetric
DIABETES AND OSTEOPOROSIS RISK

Metformin use is associated with a lower risk of osteoporosis in adult women independent of type 2 diabetes mellitus and obesity. REDLINC IX study

ORCID Icon, ORCID Icon, , ORCID Icon, , , , , , , ORCID Icon, , , ORCID Icon, , ORCID Icon, ORCID Icon, ORCID Icon, , & show all
Pages 421-425 | Received 05 Dec 2019, Accepted 15 Jan 2020, Published online: 29 Jan 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Jerilynn C. Prior, Sonia Shirin & Azita Goshtasebi. (2023) Bone health and prevalent fractures in women with polycystic ovary syndrome: a meta-analysis and endocrine-context pathophysiology review. Expert Review of Endocrinology & Metabolism 18:4, pages 283-293.
Read now
Jing Liu, Zhihong Liu, Ming Lu & Yanrong Zhang. (2023) The combination of linagliptin and metformin rescues bone loss in type 2 diabetic osteoporosis. Journal of Drug Targeting 31:6, pages 646-654.
Read now
Kathrin Kahnert, Rudolf A Jörres, Tanja Lucke, Franziska C Trudzinski, Pontus Mertsch, Christiane Bickert, Joachim H Ficker, Jürgen Behr, Robert Bals, Henrik Watz, Tobias Welte, Claus F Vogelmeier & Peter Alter. (2021) Lower Prevalence of Osteoporosis in Patients with COPD Taking Anti-Inflammatory Compounds for the Treatment of Diabetes: Results from COSYCONET. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 3189-3199.
Read now

Articles from other publishers (16)

Anastasia Marchenko. (2023) Sclerostin-dependent mechanisms of osteoporosis in patients with type 2 diabetes and obesity. Ukrainian Scientific Medical Youth Journal 142:4, pages 87-93.
Crossref
Rui Lin, Bilian Xu, Zhiqiang Ye, Yin Gao, Haiping Fang, Jintong Song, Dahong Liang, Lingna Liu, Zilong Hu, Min Zhang, Jinsong Wei, Feifu Deng, Xiangxin Zhong, Liao Cui & Yanzhi Liu. (2023) Metformin attenuates diabetes-induced osteopenia in rats is associated with down-regulation of the RAGE-JAK2-STAT1 signal axis. Journal of Orthopaedic Translation 40, pages 37-48.
Crossref
Yining Wang, Liming Yu, Zhiqiang Ye, Rui Lin, Antonia RuJia Sun, Lingna Liu, Jinsong Wei, Feifu Deng, Xiangxin Zhong, Liao Cui, Li Li & Yanzhi Liu. (2023) Association of metformin use with fracture risk in type 2 diabetes: A systematic review and meta-analysis of observational studies. Frontiers in Endocrinology 13.
Crossref
Faisal E. Aljofi, Aminah Alesawy, Bader Alzaben, Marwa Alshaikh, Norah Alotaibi, Hajer A. Aldulaijan, Sami Alshehri, Eman Aljoghaiman, Yousif A. Al-Dulaijan & Mishali AlSharief. (2023) Impact of Metformin on Periodontal and Peri-Implant Soft and Hard Tissue. International Journal of Environmental Research and Public Health 20:2, pages 1095.
Crossref
Xudong Xie, Liangcong Hu, Bobin Mi, Hang Xue, Yiqiang Hu, Adriana C. Panayi, Yori Endo, Lang Chen, Chenchen Yan, Ze Lin, Hui Li, Wu Zhou & Guohui Liu. (2022) Metformin alleviates bone loss in ovariectomized mice through inhibition of autophagy of osteoclast precursors mediated by E2F1. Cell Communication and Signaling 20:1.
Crossref
JunWei Sun, Qi Liu, Huan He, Lanlan Jiang, Kok Onn Lee, Dongmei Li & Jianhua Ma. (2022) Metformin treatment is associated with an increase in bone mineral density in type 2 diabetes mellitus patients in China: A retrospective single center study. Diabetes & Metabolism 48:5, pages 101350.
Crossref
Amin Hasanvand. (2022) The role of AMPK-dependent pathways in cellular and molecular mechanisms of metformin: a new perspective for treatment and prevention of diseases. Inflammopharmacology 30:3, pages 775-788.
Crossref
Yanhong Song, Ziyi Wu & Ping Zhao. (2022) The Function of Metformin in Aging-Related Musculoskeletal Disorders. Frontiers in Pharmacology 13.
Crossref
Qiyun Zhou, Zhiqiang Guan, Shengfu Liu, Yanjiao Xuan, Gang Han, Hua Chen, Xiao Jin, Kun Tao & Zhiyuan Guan. (2022) The effects of metformin and alendronate in attenuating bone loss and improving glucose metabolism in diabetes mellitus mice. Aging 14:1, pages 272-285.
Crossref
Moein Ala & Mahan Ala. (2021) Metformin for Cardiovascular Protection, Inflammatory Bowel Disease, Osteoporosis, Periodontitis, Polycystic Ovarian Syndrome, Neurodegeneration, Cancer, Inflammation and Senescence: What Is Next?. ACS Pharmacology & Translational Science 4:6, pages 1747-1770.
Crossref
Simone Antonini & Gherardo Mazziotti. (2021) Ruolo della metformina nella prevenzione dell’osteoporosi. L'Endocrinologo 22:6, pages 578-578.
Crossref
Jaana van Gastel, Hanne Leysen, Jan Boddaert, Laura vangenechten, Louis M. Luttrell, Bronwen Martin & Stuart Maudsley. (2021) Aging-related modifications to G protein-coupled receptor signaling diversity. Pharmacology & Therapeutics 223, pages 107793.
Crossref
Iacopo Chiodini, Agostino Gaudio, Andrea Palermo, Nicola Napoli, Fabio Vescini, Alberto Falchetti, Daniela Merlotti, Cristina Eller-Vainicher, Vincenzo Carnevale, Alfredo Scillitani, Giuseppe Pugliese, Domenico Rendina, Antonio Salcuni, Francesco Bertoldo, Stefano Gonnelli, Ranuccio Nuti, Vincenzo Toscano, Vincenzo Triggiani, Simone Cenci & Luigi Gennari. (2021) Management of bone fragility in type 2 diabetes: Perspective from an interdisciplinary expert panel. Nutrition, Metabolism and Cardiovascular Diseases 31:8, pages 2210-2233.
Crossref
Desye Gebrie, Desalegn Getnet & Tsegahun Manyazewal. (2021) Cardiovascular safety and efficacy of metformin-SGLT2i versus metformin-sulfonylureas in type 2 diabetes: systematic review and meta-analysis of randomized controlled trials. Scientific Reports 11:1.
Crossref
Samir Morsli & Ilaria Bellantuono. (2021) The use of geroprotectors to prevent multimorbidity: Opportunities and challenges. Mechanisms of Ageing and Development 193, pages 111391.
Crossref
Myat Aung, Saba Amin, Azouba Gulraiz, Fenil R Gandhi, Julio A Pena Escobar & Bilal Haider Malik. (2020) The Future of Metformin in the Prevention of Diabetes-Related Osteoporosis. Cureus.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.